Joseph Grant, MD
General Practice · Sumter, SCNPI 1639135239
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $187,193 of the $187,262 with a category attached, or 100.0%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 87.8% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $48,547, 2.1 times the $22,880 reported in 2019. Among general practice clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $2013.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$164K
- Shire North American Group Inc$23K
- Masimo Corporation$20
- Supernus Pharmaceuticals, Inc.$17
- GSK$13
What the payments were for
- Consulting fees$187,193100%
- Food & beverage$690%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 78 | $164,331 |
| Shire North American Group Inc | 12 | $22,880 |
| Masimo Corporation | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| GSK | 1 | $13 |
How this compares
$187,262 in reported general payments places this provider in the 95th percentile of 1,367 general practice providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 12 | $104,423 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $13,050 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $505 |
| Ondansetron OdtOndansetron | 67 | $491 |
| Atorvastatin Calcium | 15 | $186 |
| Rosuvastatin Calcium | 16 | $141 |
| Omeprazole | 11 | $97 |
| Potassium Chloride | 19 | $88 |
| Meloxicam | 25 | $82 |
| Amlodipine Besylate | 16 | $71 |
| Levothyroxine Sodium | 13 | $61 |
| Prednisone | 14 | $22 |
| Pantoprazole Sodium | 11 | $7 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $13 | $13,05012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,367 general practice providers in South Carolina.
Other general practice in Sumter
- Thaddeus VincentSumter$16K
- Christopher CampbellLexington$166K
- Jeffrey HorowitzMurrells Inlet$152K
- Amanda SeayMount Pleasant$146K
- Jon JulianTravelers Rest$141K
- Timothy SniderGreenwood$122K
- Anthony MennitoBamberg$120K
- Coty FishburneRock Hill$119K
- Rukudzo MazaiwanaOrangeburg$70K
- Benjamin DanielGreenville$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.